Кардиоваскулярная терапия и профилактика, 2008 The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev +4 more
doaj
Systematic adjudication of myocardial infarction end-points in an international clinical trial
Current Controlled Trials in Cardiovascular Medicine, 2001 Background Clinical events committees (CEC) are used routinely to adjudicate suspected end-points in cardiovascular trials, but little information has been published about the various processes used.
Lee Kerry L +16 more
doaj +1 more source
Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
Revista Portuguesa de Cardiologia, 2019 This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
Daniel Caldeira, Hélder Pereira
doaj +1 more source
Inhibition of platelet mediated arterial thrombosis and platelet granule exocytosis by 3'4'-dihydroxyflavonol and quercetin [PDF]
, 2013 Flavonols are polyphenolic compounds with broad-spectrum kinase inhibitory, as well as potent anti-oxidant and anti-inflammatory properties. Anti-platelet potential of quercetin (Que) and several related flavonoids have been reported; however, few ...
Jackson, D +3 more
core
Early Percutaneous Coronary Intervention, Platelet Inhibition With Eptifibatide, and Clinical Outcomes in Patients With Acute Coronary Syndromes [PDF]
, 2000 Neal S. Kleiman +12 more
openalex +1 more source
The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. [PDF]
, 2020 Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed.
Ballas, Samir K
core +1 more source
Emerging drugs for sickle cell anemia. [PDF]
, 2015 INTRODUCTION: The search for effective therapeutic interventions for sickle cell disease (SCD) has been an ongoing endeavor for over 50 years. During this period, only hydroxyurea (HU), which received US FDA approval in February 1998, was identified as ...
Ballas, Samir K., Singh, Priya C
core +1 more source
Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function [PDF]
, 2001 Eli I. Lev +9 more
openalex +1 more source
Acute Coronary Syndromes: Management and Secondary Prevention [PDF]
, 2018 Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core